0000899243-23-010034.txt : 20230330 0000899243-23-010034.hdr.sgml : 20230330 20230330175518 ACCESSION NUMBER: 0000899243-23-010034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230329 FILED AS OF DATE: 20230330 DATE AS OF CHANGE: 20230330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brand Florian CENTRAL INDEX KEY: 0001860682 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 23782070 MAIL ADDRESS: STREET 1: C/O ATAI LIFE SCIENCES N.V. STREET 2: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 BUSINESS PHONE: (617)-699-5876 MAIL ADDRESS: STREET 1: 524 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-29 0 0001840904 ATAI Life Sciences N.V. ATAI 0001860682 Brand Florian WALLSTRASSE 16 BERLIN 2M 10179 GERMANY 0 1 0 0 See Remarks 0 Common Shares 2023-03-29 4 P 0 70000 1.4794 A 70000 D Common Shares 2333 I By Spouse The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.40 to $1.55. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. Co-Founder & Chief Executive Officer /s/ Ryan Barrett, Attorney-in-fact 2023-03-30